Bromantane (Ladasten) — Supplements
Soviet-era actoprotector and anxiolytic with dopaminergic and serotonergic mechanisms, used for fatigue resistance, cognitive performance, and physical endurance under stress.
Overview
Bromantane (also known as Ladasten or N-(2-adamantyl)-2-bromaniline) is an atypical psychostimulant and actoprotector originally developed in the Soviet Union in the 1980s for military use, designed to enhance physical and mental performance under extreme environmental stress (heat, cold, altitude) without the dependence liability of traditional stimulants. It was approved in Russia as a prescription anxiolytic and psychostimulant (Ladasten) for neurasthenia and asthenic conditions. Bromantane's mechanism is uniquely dual: it upregulates tyrosine hydroxylase (TH) and DOPA decarboxylase (AADC), increasing dopamine and serotonin synthesis rather than releasing or blocking reuptake of monoamines — making it non-habit-forming and producing no acute tolerance. It also has GABA-A potentiating properties, providing anxiolytic effects. Olympic athletes were found to have used bromantane during the 1996 Atlanta Games, leading to a number of disqualifications, and it remains on the WADA prohibited list. In the nootropic community it is popular as a 'clean' dopaminergic stimulant that builds rather than depletes catecholamine stores.
Indications
- Mental and physical fatigue resistance (asthenic syndrome)
- Cognitive performance under stress
- Anxiolytic support without sedation
- Dopaminergic tone restoration in hypodopaminergic states
- Heat and hypoxia stress adaptation
- Motivation and drive support
Mechanism of Action
Bromantane transcriptionally upregulates tyrosine hydroxylase (TH) — the rate-limiting enzyme in dopamine synthesis — and DOPA decarboxylase (AADC), increasing dopamine and serotonin production rather than depleting stores
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| Bromantane | 25 mg | Once daily (morning) | Starting dose; assess tolerance over 1-2 weeks |
| Bromantane | 50 mg | Once daily (morning) | Standard dose range used in Russian clinical studies |
| Bromantane | 100 mg | Once daily (morning) | Upper range; higher risk of side effects; not recommended beyond 4-week cycles |
Safety & Contraindications
- WADA-prohibited substance: banned in competitive sports as an actoprotector/psychostimulant — not for use by competitive athletes subject to testing
- Not FDA-approved or reviewed; not legal for sale as a dietary supplement in the USA; sold as a research chemical
- Long-term human safety data is very limited — most human trials are Russian-language studies from the 1990s-2000s
- Potential for mood dysregulation at higher doses (>50 mg/day)
- Avoid combining with MAO inhibitors or other dopaminergic agents without medical supervision
- Headache, nausea, and irritability reported at higher doses
- Legal status varies by country — verify local regulations before obtaining